Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease

Atypical antipsychotic (AAP) medications that have revolutionized the treatment of mental illness have become stigmatized by metabolic side effects, including obesity and diabetes. It remains controversial whether the defects are treatment induced or disease related. Although the mechanisms underlyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Teff, Karen L., Rickels, Michael R., Grudziak, Joanna, Fuller, Carissa, Nguyen, Huong-Lan, Rickels, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749337/
https://www.ncbi.nlm.nih.gov/pubmed/23835329
http://dx.doi.org/10.2337/db13-0430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749337/
https://www.ncbi.nlm.nih.gov/pubmed/23835329
http://dx.doi.org/10.2337/db13-0430

Ejemplares similares